Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas
A Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas
Advanced Solid Tumors|Lymphomas
DRUG: ZIO-101-C (Darinaparsin)
toxicities, 6 months
pharmacokinetics, 6 months
A Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas